Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 330.93 K131.92 K263.7 K2.09 M143.3 K136.93 K 2.63 M Research & development —————— — Operating income -330.93 K-131.92 K-263.7 K-2.09 M-143.3 K-136.93 K -2.63 M Non-Operating Income, Total 1.59 M2.42 M2.45 M2.3 M2.11 M1.86 M 8.73 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 1.59 M2.42 M2.45 M2.3 M2.11 M1.86 M 8.73 M Unusual income/expense —————— — Pretax income 1.25 M2.29 M2.18 M212.96 K1.97 M1.73 M 6.09 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 1.25 M2.29 M2.18 M212.96 K1.97 M1.73 M 6.09 M Discontinued operations —————— — Net income 1.25 M2.29 M2.18 M212.96 K1.97 M1.73 M 6.09 M Dilution adjustment 2.92 M2.42 M2.45 M14.29 M2.11 M1.86 M 20.71 M Preferred dividends 2.92 M2.42 M2.45 M14.29 M2.11 M1.86 M 20.71 M Diluted net income available to common stockholders 1.25 M2.29 M2.18 M212.96 K1.97 M1.73 M 6.09 M Basic earnings per share (Basic EPS) 0.050.070.0700.050.06 0.18 Diluted earnings per share (Diluted EPS) 0.050.070.0700.050.06 0.18 Average basic shares outstanding 9.61 M10.07 M10.21 M10.45 M10.72 M10.72 M — Diluted shares outstanding 10.33 M10.42 M10.45 M10.63 M10.72 M10.72 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —